GR3035683T3 - Tetanus vaccine production. - Google Patents

Tetanus vaccine production.

Info

Publication number
GR3035683T3
GR3035683T3 GR20010400533T GR20010400533T GR3035683T3 GR 3035683 T3 GR3035683 T3 GR 3035683T3 GR 20010400533 T GR20010400533 T GR 20010400533T GR 20010400533 T GR20010400533 T GR 20010400533T GR 3035683 T3 GR3035683 T3 GR 3035683T3
Authority
GR
Greece
Prior art keywords
pct
vaccine production
tetanus vaccine
sec
date
Prior art date
Application number
GR20010400533T
Other languages
English (en)
Inventor
Anthony James Sheppard
Peter Anthony Knight
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3035683(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of GR3035683T3 publication Critical patent/GR3035683T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GR20010400533T 1992-07-31 2001-03-30 Tetanus vaccine production. GR3035683T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929216351A GB9216351D0 (en) 1992-07-31 1992-07-31 Vaccine production
PCT/GB1993/001037 WO1994003206A1 (en) 1992-07-31 1993-05-20 Tetanus vaccine production

Publications (1)

Publication Number Publication Date
GR3035683T3 true GR3035683T3 (en) 2001-06-29

Family

ID=10719649

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400533T GR3035683T3 (en) 1992-07-31 2001-03-30 Tetanus vaccine production.

Country Status (14)

Country Link
US (1) US6060067A (el)
EP (1) EP0652771B2 (el)
JP (1) JP3901212B2 (el)
AT (1) ATE199059T1 (el)
AU (1) AU690518B2 (el)
CA (1) CA2141410C (el)
DE (1) DE69329922T3 (el)
DK (1) DK0652771T4 (el)
ES (1) ES2157219T5 (el)
GB (1) GB9216351D0 (el)
GR (1) GR3035683T3 (el)
NZ (1) NZ252253A (el)
PT (1) PT652771E (el)
WO (1) WO1994003206A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2518669C (en) * 2003-03-13 2014-07-29 Glaxosmithkline Biologicals S.A. Purification process
CN1641034B (zh) * 2004-01-14 2010-04-28 中国药品生物制品检定所 破伤风毒素重组抗原制备方法及其应用
US8883172B2 (en) 2007-06-14 2014-11-11 The Secretary Of State For Health Chemically modified peptides with improved immunogenicity
GB2456549A (en) * 2008-01-18 2009-07-22 Health Prot Agency Modified botulinum neurotoxin serotype E (BoNT/E) peptides
SG11201502599TA (en) 2012-10-12 2015-05-28 Glaxosmithkline Biolog Sa Non-cross-linked acellular pertussis antigens for use in combination vaccines
US11027005B2 (en) 2016-10-20 2021-06-08 Km Biologics Co., Ltd. Method for producing Hib conjugate vaccine using PRP with lowered molecular weight
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition
CN115448981A (zh) * 2022-10-20 2022-12-09 北京智飞绿竹生物制药有限公司 一种吸附破伤风疫苗的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB969772A (en) * 1961-01-05 1964-09-16 Wellcome Found Toxoids and their production
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
AU646019B2 (en) * 1990-02-12 1994-02-03 Smithkline Beecham Biologicals (Sa) Novel vaccine and method therefor

Also Published As

Publication number Publication date
EP0652771B2 (en) 2010-07-14
EP0652771B1 (en) 2001-02-07
CA2141410A1 (en) 1994-02-17
DK0652771T4 (da) 2010-10-25
AU690518B2 (en) 1998-04-30
CA2141410C (en) 2006-10-31
JPH07509481A (ja) 1995-10-19
ES2157219T5 (es) 2010-10-26
WO1994003206A1 (en) 1994-02-17
EP0652771A1 (en) 1995-05-17
DK0652771T3 (da) 2001-02-26
ES2157219T3 (es) 2001-08-16
PT652771E (pt) 2001-05-31
JP3901212B2 (ja) 2007-04-04
DE69329922D1 (de) 2001-03-15
US6060067A (en) 2000-05-09
GB9216351D0 (en) 1992-09-16
ATE199059T1 (de) 2001-02-15
DE69329922T3 (de) 2010-12-09
AU4082693A (en) 1994-03-03
DE69329922T2 (de) 2001-05-23
NZ252253A (en) 1996-10-28

Similar Documents

Publication Publication Date Title
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
LU91610I2 (fr) Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
DE69333065D1 (de) Alkalische lipase
FI960977A0 (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
ES2119812T3 (es) Catalasa, su produccion y uso.
GR3035683T3 (en) Tetanus vaccine production.
FI92334C (fi) Menetelmä syklosporiinien tuottamiseksi ja menetelmässä käytettävä uusi Tolypocladium-kanta
ATE108826T1 (de) Heparinase produzierender mikroorganismus des stammes bacillus, neue heparinase und verfahren zu ihrer herstellung.
JPS56106593A (en) Alkali protease m3
NO951750D0 (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
CA2004206A1 (en) Method for preparing pertussis toxin toxoid
AU673344B2 (en) Vaccines based on streptokinase
AU633707B2 (en) Novel heat-resistant beta-galactosyltransferase, its production process and its use
IE32044B1 (en) Process for the manufacture of a tetanus-vaccine
CA2109233A1 (en) Process for Producing Vaccine for Bacterial Toxin Belonging to RTX Toxin Family
ES2141258T3 (es) Enzima y su uso en la preparacion de acido (s)-pipecolico.
RU94003337A (ru) Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина
JPS572684A (en) Preparation of amylase inhibitor ai-b
SE9403636D0 (sv) Vaccine preparation
ITMI913375A1 (it) Procedimento per la produzione di neuraminidasi
RU94003328A (ru) Штамм бактерий proteus mirabilis - продуцент термолабильного энтеротоксина
EP0316907A3 (en) Enzyme inhibitor and method of producing the same
MY105945A (en) Process for producing l-glutamic acid.
JPS6479118A (en) Antitumor agent